GLP-1 is changing the food market. What do WHO guidelines mean for candy and alcohol producers?

Published on December 1, 2025, the global guidelines from the World Health Organization (WHO) represent a turning point for the food market. The official inclusion of GLP-1 medications into medical standards ends the phase of speculation. Pharmacological treatment of obesity is becoming a sanctioned systemic procedure, permanently shaping consumer purchasing decisions. The WHO recommendation for the use of GLP-1 medications in adults changes the market perspective. Obesity has been clearly defined as a chronic disease requiring long-term treatment, which creates a constant, growing segment of consumers. New diet forces reformulation of products Key for food producers is the indication that pharmacotherapy cannot function alone. The organization emphasizes the necessity of using an approach that mandatorily includes a healthy diet and physical activity. Patients are therefore looking for products tailored to therapy, that is, those that provide necessary nutrients with a ...